Toggle light / dark theme

But OpenAI isn’t Altman’s only project, and it’s not even his only project with ambitions to change the world. He is also a co-founder of a company called Tools for Humanity, which has the lofty goal of protecting people from the economic devastation that may arise from AI taking human jobs. The company’s first major project is Worldcoin, which uses an evil-looking metallic orb—called the Orb—to take eyeball scans from people all over the world.

Those scans are converted into unique codes that confirm you are a real, individual human, not a bot. In the future, this will theoretically grant you access to a universal basic income parceled out through Worldcoin’s cryptocurrency, WLD. (You will want this because you will not be able to find work.) More than 2 million people in 35 countries have been scanned already, according to Tools for Humanity’s World ID app. Although it’s not yet available in the United States, the WLD token has been distributed elsewhere, and the company has also recruited users through cash incentives in countries such as Indonesia and Kenya.

The US firm best known for its gaming tech has long been ahead of the curve in supplying the tools needed by tech developers.

It’s not often that the jaws of Wall Street analysts drop to the floor but late last month it happened: Nvidia, a company that makes computer chips, issued sales figures that blew the street’s collective mind. It had pulled in $13.5bn in revenue in the last quarter, which was at least $2bn more than the aforementioned financial geniuses had predicted. Suddenly, the surge in the company’s share price in May that had turned it into a trillion-dollar company made sense.

Well, up to a point, anyway. But how had a company that since 1998 – when it released the revolutionary… More.

Under the proposal, developing face recognition and other “high risk” applications of AI would also require a government license. To obtain one, companies would have to test AI models for potential harm before deployment, disclose instances when things go wrong after launch, and allow audits of AI models by an independent third party.

The framework also proposes that companies should publicly disclose details of the training data used to create an AI model and that people harmed by AI get a right to bring the company that created it to court.

The senators’ suggestions could be influential in the days and weeks ahead as debates intensify in Washington over how to regulate AI. Early next week, Blumenthal and Hawley will oversee a Senate subcommittee hearing about how to meaningfully hold businesses and governments accountable when they deploy AI systems that cause people harm or violate their rights. Microsoft president Brad Smith and the chief scientist of chipmaker Nvidia, William Dally, are due to testify.

Qualcomm CEO Cristiano Amon said the company’s upcoming Snapdragon Summit in October could lead to major developments in mobile technology.

New cases from smartphone makers and other manufacturers the company works with “could create a new upgrade cycle for phones,” Amon said.

In 2022, global smartphone sales tumbled 18.3% year-over-year to 1.21 billion, the lowest level since 2013, according to data from market research firm IDC.

The CEO of U.S. chip giant Qualcomm thinks artificial intelligence could give the smartphone market a fresh lease on life.

Came across this. Any aviation fans? MIT does it again but this time with propellers.


Hope you all enjoy it.
Dont forget to subscribe and give a thumbs up.

This video is made with non-profit or does not represent another company. I do not own the copyrights to the “music” in the video!

That’s perfect and from one of the most technological countries. It’s late and I saved it for watching later but I can imagine what is in this video. AI is always useful especially in medicine.


[Skip Intro] 0:22
Learn more about science on NHK WORLD-JAPAN:
https://www3.nhk.or.jp/nhkworld/en/ondemand/category/23/?cid…9-sv303-hp.
More quality content available on NHK WORLD-JAPAN:
https://www3.nhk.or.jp/nhkworld/en/ondemand/video/?cid=wohk-yt-2309-sv303-hp.

The integration of artificial intelligence into healthcare seeks to reduce diagnosis errors while increasing humanity.

The Conboys’ statement on plasma dilution is important:

The pair are quick to add that this isn’t going to have a Benjamin Button effect, and the research “wasn’t geared to make old people young” – even if this idea is being bio-hacked around the world. “It was clear that there were improvements after a couple of procedures,” says Irina. “[But] it’s not really healthy or rejuvenating to drain somebody of 70% of their blood and replace it with something.” She warns people to wait until more research is done.

Still, they believe that in the next five years we will see huge advancements in prolonging life treatments – including taking a pill instead of getting blood, and a “fountain of middle age”. “People will be able to have this high quality, productive life where they are healthy for many more decades,”


A fascinating and often terrifying new podcast delves into the lengths ‘longevity superstars’ will go to make 90 the new 50, from swapping blood with the young to designing the first ‘post-humans’

Will ChatGPT revolutionize our approach to radiology or has it already started shaping a new era of radiological excellence?

Dr. Rajesh Bhayana, an abdominal radiologist and the Director of Technology in the Joint Department of Medical Imaging in Toronto sits down with the Radiologists host Satheesh Krishna to talk about this fastest growing consumer application in history and its application in radiology.

Listen to all previous episodes and subscribe to our podcast Radiologists here: https://universitymedicalimagingtoronto.ca/radiologists-podcast/

BARDA is part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services.

The NTxscribe platform is a cell-free, continuous flow manufacturing system that reportedly delivers scalable RNA (including mRNA and self-amplifying RNA) materials in a tabletop footprint. This enzymatic process is designed to provide a low cost and rapidly deployable, vertically integrated manufacturing system, according to Jamie Coffin, PhD, CEO of NTx. Through this program, the system is being evaluated for its express development of RNA vaccines and therapeutics for infectious diseases, as well as its capability for distributed biomanufacturing.

“The traditional batch processes for developing vaccines and other biologics are burdensome and cannot be scaled quickly in the event of an emergency,” said Coffin. “Over the course of this project, we will aim to prove that NTxscribe can help BARDA meet its goals toward decentralized and rapidly deployable vaccine manufacturing.”